Protracted fever after a journey to India and Nepal: A case of persistent Salmonella paratyphi infection

Journal of Travel Medicine

Volumn 11, Issue 4, 2004, Pages 257-259

  Piersma, Djura ^a   Overbosch, David ^b   Petit, Pieter ^c   Van Genderen, Perry J J ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Havenziekenhuis   (Netherlands)

^c Zuiderziekenhuis   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CARBENICILLIN; CEFALOTIN; CEFAZOLIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; MINOCYCLINE; NALIDIXIC ACID; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; PARACETAMOL; TIMENTIN; TOBRAMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CHRONIC DISEASE; CLINICAL FEATURE; FEVER; HUMAN; INDIA; LABORATORY TEST; MALE; NEPAL; PERSISTENT INFECTION; PROTRACTED FEVER; SALMONELLA PARATYPHI; SALMONELLOSIS; TRAVEL; TYPHOID FEVER;

EID: 4043148513     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.2310/7060.2004.19012     Document Type: Article

References (9)

1. Parry CM, Hien TT, Dougan G, et al. Typhoid fever. N Engl J Med 2002; 347:1770-1782.
2. Rowe B, Ward LR, Threlfall EJ. Multidrug-resistant Salmonella typhi: a worldwide epidemic. Clin Infect Dis 1997; 24(Suppl 1): S106-S109.
3. Alam MN, Haq SA, Das KK, et al. Efficacy of ciprofloxacin in enteric fever: comparison of treatment duration in sensitive and multidrug-resistant Salmonella. Am J Trop Med Hyg 1995; 53:306-311.
4. Tran TH, Bethell DB, Nguyen TT, et al. Short course of ofloxacin for treatment of multidrug-resistant typhoid. Clin Infect Dis 1995; 20:917-923.
5. Girgis NI, Butler T, Frenck RW, et al. Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. Antimicrob Agents Chemother 1999; 43:1441-1444.
6. Cao XT, Kneen R, Nguyen TA, et al. A comparative study of ofloxacin and cefixime for treatment of typhoid fever in children. The Dong Nai Pediatric Center Typhoid Study Group. Pediatr Infect Dis J 1999; 18:245-248.
7. Ackers ML, Puhr ND, Tauxe RV, Mintz ED. Laboratory-based surveillance of Salmonella serotype Typhi infections in the United States: antimicrobial resistance on the rise. JAMA 2000; 283:2668-2673.
8. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: thirteenth informational supplement. NCLLS document M100-S13 (M7). Wayne, Pa: NCLLS, 2003.
9. Crump JA, Barrett TJ, Nelson JT, Angulo FJ. Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae. Clin Infect Dis 2003; 37:75-81.